Page last updated: 2024-11-02

piracetam and Opsoclonus-Myoclonus Syndrome

piracetam has been researched along with Opsoclonus-Myoclonus Syndrome in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Opsoclonus-Myoclonus Syndrome: A neurological condition that is characterized by uncontrolled rapid irregular movements of the eye (OPSOCLONUS) and the muscle (MYOCLONUS) causing unsteady, trembling gait. It is also known as dancing eyes-dancing feet syndrome and is often associated with neoplasms, viral infections, or autoimmune disorders involving the nervous system.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sharma, C1
Acharya, M1
Kumawat, BL1
Kochar, A1
Bhandari, HS1

Reviews

1 review available for piracetam and Opsoclonus-Myoclonus Syndrome

ArticleYear
Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies.
    BMJ case reports, 2012, Aug-08, Volume: 2012

    Topics: Adult; Anticonvulsants; Anxiety; Ataxia; Autoantibodies; Diagnosis, Differential; Earache; Female; F

2012

Other Studies

1 other study available for piracetam and Opsoclonus-Myoclonus Syndrome

ArticleYear
'Dancing eyes, dancing feet syndrome' in small cell lung carcinoma.
    BMJ case reports, 2014, Apr-23, Volume: 2014

    Topics: Baclofen; Humans; Levetiracetam; Lung; Lung Neoplasms; Male; Middle Aged; Muscle Relaxants, Central;

2014